XML 20 R5.htm IDEA: XBRL DOCUMENT v3.24.2
Consolidated Statements of Changes in Equity - EUR (€)
€ in Millions
Total
Attributable to equity holders of Sanofi
Share capital
Additional paid-in capital
Treasury shares
Reserves and retained earnings
Stock options and other share-based payments
Other comprehensive income
Attributable to non-controlling interests
Beginning balance at Dec. 31, 2022 € 75,152 € 74,784 € 2,522 € 125 € (706) € 66,734 € 4,658 € 1,451 € 368
Other comprehensive income for the period (973) (965)       85   (1,050) (8)
Net income for the period 3,456 3,430       3,430     26
Comprehensive income 2,483 2,465       3,515   (1,050) 18
Dividend paid out of earnings (4,454) (4,454)       (4,454)      
Payment of dividends to non-controlling interests (49) 0             (49)
Share repurchase program [1] (363) (363)     (363)        
Share-based payment plans:                  
Exercise of stock options 18 18 0 18          
Issuance of restricted shares and vesting of existing restricted shares 0 0 3 (3) 112 (112)      
Value of services obtained from employees 160 160         160    
Tax effects of share-based payments 8 8         8    
Other changes arising from issuance of restricted shares 2 2       2      
Other movements (b) [2] (10) 9       9     (19)
Ending balance at Jun. 30, 2023 72,947 72,629 2,525 140 (957) 65,694 4,826 401 318
Beginning balance at Dec. 31, 2022 75,152 74,784 2,522 125 (706) 66,734 4,658 1,451 368
Other comprehensive income for the period (1,603)                
Net income for the period 5,436                
Comprehensive income 3,833                
Ending balance at Dec. 31, 2023 74,353 74,040 2,530 313 (1,184) 67,499 4,944 (62) 313
Beginning balance at Jun. 30, 2023 72,947 72,629 2,525 140 (957) 65,694 4,826 401 318
Other comprehensive income for the period (630) (625)       (162)   (463) (5)
Net income for the period 1,980 1,970       1,970     10
Comprehensive income 1,350 1,345       1,808   (463) 5
Payment of dividends to non-controlling interests (10)               (10)
Share repurchase program [1] (230) (230)     (230)        
Share-based payment plans:                  
Exercise of stock options 19 19 1 18          
Employee share ownership plan 159 159 4 155          
Value of services obtained from employees 123 123         123    
Tax effects of share-based payments (5) (5)         (5)    
Ending balance at Dec. 31, 2023 74,353 74,040 2,530 313 (1,184) 67,499 4,944 (62) 313
Other comprehensive income for the period 1,233 1,225       166   1,059 8
Net income for the period 2,263 2,246       2,246     17
Comprehensive income 3,496 3,471       2,412   1,059 25
Dividend paid out of earnings (4,704) (4,704)       (4,704)      
Payment of dividends to non-controlling interests (31) 0             (31)
Share repurchase program [1] (302) (302)     (302)        
Share-based payment plans:                  
Exercise of stock options 7 7 0 7          
Issuance of restricted shares and vesting of existing restricted shares [1] 0 0 3 (3) 115 (115)      
Value of services obtained from employees 173 173         173    
Tax effects of share-based payments 4 4         4    
Other changes arising from issuance of restricted shares 1 1       1      
Ending balance at Jun. 30, 2024 € 72,997 € 72,690 € 2,533 € 317 € (1,371) € 65,093 € 5,121 € 997 € 307
[1] See Note B.8.2. (for amounts relating to 2023, see Note D.1.5.4. to the consolidated financial statements for the year ended December 31, 2023).
[2] This line mainly comprises the impact on non-controlling interests arising from divestments and acquisitions.